Form 4: CME Group Director Receives Stock Grant

Bryan T. Durkin, a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the company's annual equity compensation program.

Summary

• Bryan T. Durkin, a Director of CME Group Inc., was granted 645 shares of Class A Common Stock on June 25, 2026.
• This grant is part of the company's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan.
• The shares are fully vested and not subject to any further vesting conditions.
• Following this transaction, Mr. Durkin beneficially owns 43,652 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine director compensation event rather than a significant financial or strategic development for the company.

Positives

• Director compensation through stock grants indicates alignment of management interests with shareholders.
• The grant of fully vested shares provides immediate value to the director.
• The transaction is part of a pre-established annual compensation program, suggesting a structured approach to director remuneration.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a director's stock grant.

Industry Context

StockSavvy.ai notes that director stock grants are a common practice in the financial services industry, particularly for exchange operators like CME Group, to attract and retain experienced board members and align their interests with long-term company performance.

Stakeholder Impact

• Shareholders: The stock grant is a form of compensation, which is a standard cost of doing business. The alignment of director interests with shareholders is generally viewed positively.

Key Dates

Keywords

CME Group, Form 4, Director Compensation, Stock Grant, Class A Common Stock, Equity Compensation, SEC Filing